Press release
Global Angina Market Report: 2020 worldwide Industry Analysis By key Players - Sanofi, Gilead, AstraZeneca, Pfizer, Eli Lilly, Amgen, GlaxoSmithKline, Novartis AG, Forest Laboratories In
Global Angina Market
Global Angina Market is expected to reach USD 13087.6 Million by 2025, from USD 8791 Million in 2017 growing at a CAGR of 5.1% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Report + All Related Graphs & Charts @
https://databridgemarketresearch.com/request-a-sample/?dbmr=global-angina-market
Report Segmentation:-
Global Angina Market, By Therapeutic Classes (beta blockers, nitrates, calcium channel blockers and Angiotensin-converting enzyme inhibitors and others), By Types (stable angina and unstable angina), By End Users (Hospital-Owned and cardiology and others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)- Industry Trends and Forecast to 2025
Competitive Analysis:
The global angina market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of angina market for global, Europe, North America, Asia Pacific and South America.
Market Definition: Global Angina Market
Angina is a chest pain or discomfort arises when the heart muscles don't receive enough oxygen rich blood. Angina is not a disease but symptom of heart problems like coronary heart disease or coronary microvascular disease (MVD). According to American Heart Association, approximately 58% of patients suffering from coronary artery disease experience from angina pectoris. Prevalence of angina increases with increase age of women or men. As per American Heart association prevalence of angina rises from 0.1 to 1% in females at the age of 65 to 74 and 2.0 to 5.0% in males at the age of 45 to 54. As of 2010 survey in 2010 the estimated cost of direct and indirect treatment for angina was USD 177 Billion. In May 2017, Astrazeneca made an agreement with Recordati SpA for commercialization of Seloken or Seloken ZOK (metoprolol tartrate and metoprolol succinate) for lowering the blood pressure, relieving chest pain due to less blood supply to the heart and Logimax fixed-dose combination (metoprolol succinate and felodipine) in Europe. In 2017, Lupin received an approval from U.S. FDA for Nadolol tablets to market the generic version of cogard tablet. Enoxaparin sodium and abciximab biosimilars received approvals in the U.S., Europe and Indian markets.
Buy this Report (Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries) @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-angina-market
Major Market Drivers and Restraints:
Increased geriatric population
Increase in diabetic and hypertension population due to bad lifestyle
Development of biosimilars and biobetters.
Increase in consumption of alcohol and smoking
Downward pricing pressure owing to its commodity nature
How will the report help new companies to plan their investments in the Angina market?
The Angina market research report classifies the competitive spectrum of this industry in elaborate detail. The study claims that the competitive reach spans the companies of .
The report also mentions about the details such as the overall remuneration, product sales figures, pricing trends, gross margins, etc.
Information about the sales & distribution area alongside the details of the company, such as company overview, buyer portfolio, product specifications, etc., are provided in the study.
Any query? Enquire Here For Discount Or Report Customization: @
Some of the Major Highlights of TOC covers:
Chapter 1: Methodology & Scope
Definition and forecast parameters
Methodology and forecast parameters
Data Sources
Chapter 2: Executive Summary
Business trends
Regional trends
Product trends
End-use trends
Chapter 3: Angina Industry Insights
Industry segmentation
Industry landscape
Vendor matrix
Technological and innovation landscape
Chapter 4: Angina Market, By Region
Chapter 5: Company Profile
Business Overview
Financial Data
Product Landscape
Strategic Outlook
SWOT Analysis
Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Reasons to Purchase this Report
· Current and future of Global Angina Market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
· Regions/countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report
· The report includes the complete segmentation displayed above across all above mentioned countries
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Angina Market Report: 2020 worldwide Industry Analysis By key Players - Sanofi, Gilead, AstraZeneca, Pfizer, Eli Lilly, Amgen, GlaxoSmithKline, Novartis AG, Forest Laboratories In here
News-ID: 1907113 • Views: …
More Releases from Data Bridge Market Research
Ophthalmic Ultrasound Imaging Systems Market Size, Share, Trends, Key Drivers, G …
Global Ophthalmic Ultrasound Imaging Systems Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Ophthalmic Ultrasound Imaging Systems market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the world. By…
Smartphone Sanitizer Market Size, Share, Trends, Key Drivers, Growth and Opportu …
Smartphone Sanitizer Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and insights…
Chemical Dust Suppressants Market Size, Share, Trends, Key Drivers, Growth and O …
Chemical Dust Suppressants Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis. With…
Farm Video Surveillance System Market Size, Share, Trends, Demand, Growth and Co …
Global Farm Video Surveillance System Market study by Data Bridge Market Research provides details about the market dynamics affecting the Farm Video Surveillance System market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Farm Video Surveillance System market analysis report is the high quality report having in-depth market research studies.
For dominating the market or industry…
More Releases for Angina
Angina Pectoris Drugs Market Set for Rapid Growth
Global Angina Pectoris Drugs Market: Overview
The demand within the global market for angina pectoris drugs has been rising on account of the focus given on treating medical conditions suffered by the geriatric population. The presence of a seamless industry for healthcare diagnostic and treatment has played a major role in market growth. Angina pectoris is a type of chest pain that is triggered due to reduced blood flow to…
Refractory Angina Market accentuating the growth 2025
Global Refractory Angina Market: Snapshot
In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows…
Angina (Angina Pectoris) Key Players - Angionetics Inc, Hemostemix Inc, and ID P …
Angina (Angina Pectoris)
Overview
Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is relieved by rest. Angina generally is a symptom of coronary artery disease. In most severe cases, it occurs with minimal effort or at rest. Symptoms include anxiety, increased or irregular heart rate, paleness and cold sweat, and a feeling of doom. Risk factors include smoking, sedentary lifestyle, high…
Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.…
Angina (Angina Pectoris) Pipeline Review, H2 2017
The Report Angina (Angina Pectoris) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2017, provides an overview of the Angina (Angina Pectoris) (Cardiovascular) pipeline landscape.
Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs…
Refractory Angina Market: Industry Survey and Outlook 2025
Global Refractory Angina Market: Snapshot
In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows…
